Glycemic Index of Date Cultivars and Date-based Products
Assessment of the Glycemic Index of Various Saudi Date Cultivars and Date-based Products. in Healthy Adults
1 other identifier
interventional
40
1 country
1
Brief Summary
Dates are widely consumed worldwide and hold substantial cultural importance in many Middle Eastern communities. Despite growing interest in measuring the glycemic response and glycemic index of foods for both research and practical applications, studies examining the glycemic properties of different date cultivars and their derived products remain limited. This study aims to determine the glycemic index (GI) and glycemic load (GL) of commonly consumed Saudi date cultivars and their derived products in healthy subjects, and to evaluate their potential impact on postprandial glucose responses. The study will consist of 4 phases as follows: phase 1: Date varieties at Tamer stage; phase 2: date varieties at Rutab stage; phase 3: Date's debs; phase 4: Date's paste. For each phase, ten subjects will be asked to attend the laboratory in the morning after an overnight fast on several occasions. Each visit will be separated from the next by a "washout" day. The reference food, 50 g of glucose dissolve in 250 ml water will be tested on 3 alternating days to diminish day to day variation of glucose tolerance. 50g equivalent carbohydrates of dates will be consumed with 250 ml of water. Participants will be blinded to the type of the dates. Glucose will be measured in capillary blood samples following the two hours of the test meal consumption, at 15 min interval (0, 15, 30, 45, 60, 90 and 120 min) . A qualified technician will perform all blood glucose measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2025
CompletedFirst Submitted
Initial submission to the registry
December 3, 2025
CompletedFirst Posted
Study publicly available on registry
December 16, 2025
CompletedDecember 31, 2025
May 1, 2025
9 months
December 3, 2025
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycemic Index
The glycemic index of each date cultivar and date-based product will be determined on designated test days by calculating the incremental area under the blood glucose response curve (iAUC) over the 120-minute postprandial period following consumption of a portion containing 50 g of available carbohydrates, relative to the iAUC of a reference glucose solution. Blood glucose measurements will be obtained at baseline (fasting) and at predefined time points up to 120 minutes after ingestion.
Baseline (fasting) and up to 120 minutes post-consumption on each test day.
Secondary Outcomes (1)
Glycemic Load (GL) of Fresh and Processed Date Products
Baseline (fasting) and up to 120 minutes post-consumption on each test day.
Study Arms (1)
Single Group - Crossover Consumption of Date Products and Glucose Reference
EXPERIMENTALAll participants will receive the glucose reference solution on three separate occasions and will consume the date or date-based product in individual sessions. Participants serve as their own control in a crossover design. Capillary blood glucose will be measured at several time points (0-120 minutes) after consumption to assess the glycemic index and load for each product.
Interventions
Participants will consume 50 g of available carbohydrates from each date or date-based product, including 13 Tamer varieties, 12 Rutab varieties, 3 types of date paste, and 3 types of date molasses. Each product will be tested in a separate session.. The intervention will also include consumption of a glucose reference solution (50 g glucose) on three separate occasions.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 18 to 55 years
- Normotensive (normal blood pressure)
- Normal fasting glucose levels
- Not taking any prescription medication
- Able and willing to provide written informed consent
You may not qualify if:
- Morbid obesity (BMI \> 40 kg/m²)
- Pre-diabetic status
- Pregnancy
- Any gastrointestinal disorders
- History of gastroenteritis within the preceding six months
- Previous gastrointestinal surgeries
- Smoking
- Presence of chronic conditions (e.g., asthma, rheumatoid arthritis)
- Presence of acute illnesses (e.g., respiratory or urinary tract infections)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Saud University
Riyadh, Saudi Arabia
Related Publications (1)
Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005 Jun;18(1):145-71. doi: 10.1079/NRR2005100.
PMID: 19079901BACKGROUND
Study Officials
- STUDY DIRECTOR
Maha Alhussain, PhD
King Saud University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 3, 2025
First Posted
December 16, 2025
Study Start
August 16, 2024
Primary Completion
May 25, 2025
Study Completion
May 25, 2025
Last Updated
December 31, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
Notably, individual participant data will not be shared to ensure the privacy and confidentiality of the study participants. The data includes personal health information and making them publicly available might risk the identification of participants despite efforts to anonymize them.